Go All-In On Actavi...
Health Care: Health Services
Ironwood Pharmaceuticals Inc. (IRWD: NASDAQ)
$12.43 0.53 | 4.45%
06/18/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 150.24M | 65.87M | 43.86M | 36.10M |
| Cost of Sales | 965.00K | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 149.28M | 65.87M | 43.86M | 36.10M |
| Selling, General, and Administrative Expenses | 108.57M | 45.92M | 27.17M | 23.98M |
| Research & Development | 113.47M | 86.09M | 77.45M | 84.89M |
| Operating Income before D & A (EBITDA) | -72.76M | -66.14M | -60.77M | -72.77M |
| Depreciation & Amortization | 12.48M | 10.00M | 6.16M | 5.25M |
| Interest Income | 197.00K | 456.00K | 614.00K | 243.00K |
| Other Income - Net | 0.00 | 900.00K | 993.00K | 600.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -85.05M | -74.78M | -65.32M | -78.38M |
| Interest Expense | 59.00K | 63.00K | 196.00K | 474.00K |
| Pre-Tax Income | -85.11M | -74.85M | -65.52M | -78.86M |
| Income Taxes | 0.00 | 3.00K | -2.94M | -296.00K |
| Minority Interest | 0.00 | 0.00 | 1.12M | -2.13M |
| Net Income From Continuing Operations | -72.62M | -64.85M | -56.41M | -71.18M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 4.55M | 0.00 |
| Net Income From Total Operations | -72.62M | -64.85M | -51.86M | -71.18M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -72.62M | -64.85M | -52.98M | -71.18M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-72.62M | -64.85M | -56.41M | -69.98M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -72.62M | -64.85M | -56.41M | -71.18M |
| Basic EPS from Continuing Ops. | -0.68 | -0.65 | -0.63 | -10.00 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.04 | 0.00 |
| Basic EPS from Total Operations | -0.68 | -0.65 | -0.59 | -10.00 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.68 | -0.65 | -0.59 | -10.00 |
| Basic Normalized Net Income/Share | -0.68 | -0.65 | -0.63 | -9.83 |
| EPS fr Continuing Ops. | -0.68 | -0.65 | -0.63 | -10.00 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.04 | 0.00 |
| EPS fr Total Ops. | -0.68 | -0.65 | -0.59 | -10.00 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.68 | -0.65 | -0.59 | -10.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.68 | -0.65 | -0.63 | -9.83 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with IRWD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Pharma Stocks With Upside
- ProBridger Management
- ContributorRocket Stocks for the Week ...
- ContributorBarron's Insider Purchases ...
Latest IRWD Headlines from TheStreet
- Short Interest In Ironwood Pharmaceuticals Moves 11% Lower 06.13.13 | 02:06 pm
- 4 Stocks Underperforming Today In The Health Services Industry 06.12.13 | 01:06 pm
- Ironwood Pharmaceuticals Is Now Oversold (IRWD) 05.22.13 | 04:05 pm
- Ironwood Pharmaceuticals Enters Oversold Territory (IRWD) 05.01.13 | 12:05 pm
- 3 Stocks Underperforming Today In The Health Services Industry 04.25.13 | 01:04 pm
- Ironwood's Constipation Drug Sales Disappoint 04.23.13 | 08:04 am
- Top Insider Trades: ATVI, SCS, KSS, IRWD 04.03.13 | 07:04 am
- Analysts' Actions: FCX IRWD RIG SCHW ULTA 03.15.13 | 08:03 am
- Cramer's 'Mad Money' Recap: The Bullish Facts 01.17.13 | 08:01 pm
- Ironwood Pharmaceuticals Inc. Stock Downgraded (IRWD) 01.17.13 | 04:01 am
Press Releases for IRWD
- Edward Owens, Ironwood Board Of Directors (Photo: Business Wire) - Business Wire 03.04.13 | 08:03 am
- Ironwood Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 04:02 pm
- Mark Currie, Ph.D., Senior Vice President, CSO, And President Of R&D Of Ironwood Pharmaceuticals, Inc. (Photo: Business Wire) - Business Wire 02.11.13 | 09:02 am
- Ironwood Pharmaceuticals Provides Fourth Quarter 2012 Investor Update - Business Wire 01.15.13 | 07:01 am
- Ironwood Pharmaceuticals To Host Fourth Quarter 2012 Investor Update Call - Business Wire 01.10.13 | 04:01 pm
- Ironwood Completes $175 Million Debt Offering - Business Wire 01.04.13 | 10:01 am
- Ironwood Pharmaceuticals To Present At J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- FACT SHEET -- Chronic Idiopathic Constipation - Business Wire 12.17.12 | 08:12 am
- Protagonist And Ironwood Expand Peptide Drug Discovery Collaboration - Business Wire 12.06.12 | 08:12 am
- Constella® (linaclotide) Approved In Europe For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)in Adults - PR Newswire 11.28.12 | 10:11 am
Partner Headlines for IRWD
- Pre-Market Most Active for May 22, 2013 : NTAP, PFE, NMR, RDS/A, RDS/B, NOK, SNE, PGTI, IRWD, GILD, VOD, ZNGA - NASDAQ 05.22.13 | 12:05 pm
- EU Approval for Ironwood's Constella - Analyst Blog - Zacks 11.30.12 | 02:11 pm
- Earnings Scorecard: Forest Labs - Analyst Blog - Zacks 10.26.12 | 06:10 pm
- Ironwood and AstraZeneca Announce Linaclotide Collaboration for China - Benzinga 10.23.12 | 09:10 am
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - NASDAQ 08.31.12 | 09:08 pm
- FDA OK's Forest-Ironwood's Linzess - Analyst Blog - Zacks 08.31.12 | 05:08 pm
- Hedging Ironwood before ruling - NASDAQ 08.28.12 | 09:08 am
- Ironwood Pharmaceuticals, Earnings Call INSIGHTS: Huge Opportunity in CC, Feeling Good About Commercial Readiness - Wall St. Cheat Sheet 07.18.12 | 11:07 am
- Delay in Forest Drug FDA Action Date - Analyst Blog - Zacks 03.30.12 | 05:03 pm
- Forest-Janssen Sue Generic Players - Analyst Blog - Zacks 03.16.12 | 07:03 pm
